Entering text into the input field will update the search result below

Sangamo Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

SA Transcripts profile picture
SA Transcripts

The following slide deck was published by Sangamo Therapeutics, Inc. in conjunction with their 2021 Q1 earnings call.

Corporate Presentation

This article was written by

SA Transcripts profile picture
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Recommended For You

Comments (4)

The only worse company in the space, IONS. Two bottom feeders!
Typical Sangamo....oblivious to their shareholders. If I shorted biotech SGMO would be the first company i'd short.
This is a very frustrating company to own. Lots of shots on net but a long way to go. My guess is they need to raise cash again before they see meaningful revenue. Only one phase 3 trial and splitting the pie with Pfizer. Splitting the pie with everyone in fact, which they consider “validating.” I’ve been long a long time here but ready to cut bait. Given all the tie ins with various pharma companies I suspect buyout is unlikely. Good luck to those who stay long I may take what little profits I have and run.
MoneyPro profile picture
@jeybolt00 RBC just gave them an "Outperform"
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About SGMO

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SGMO

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.